BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25920435)

  • 1. Mutations in the RAS and PI3K pathways are associated with metastatic location in colorectal cancers.
    Lan YT; Jen-Kou L; Lin CH; Yang SH; Lin CC; Wang HS; Chen WS; Lin TC; Jiang JK; Chang SC
    J Surg Oncol; 2015 Jun; 111(7):905-10. PubMed ID: 25920435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer.
    Tie J; Lipton L; Desai J; Gibbs P; Jorissen RN; Christie M; Drummond KJ; Thomson BN; Usatoff V; Evans PM; Pick AW; Knight S; Carne PW; Berry R; Polglase A; McMurrick P; Zhao Q; Busam D; Strausberg RL; Domingo E; Tomlinson IP; Midgley R; Kerr D; Sieber OM
    Clin Cancer Res; 2011 Mar; 17(5):1122-30. PubMed ID: 21239505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer.
    Day FL; Jorissen RN; Lipton L; Mouradov D; Sakthianandeswaren A; Christie M; Li S; Tsui C; Tie J; Desai J; Xu ZZ; Molloy P; Whitehall V; Leggett BA; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Busam D; Zhao Q; Strausberg RL; Gibbs P; Sieber OM
    Clin Cancer Res; 2013 Jun; 19(12):3285-96. PubMed ID: 23633456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.
    Lee DW; Han SW; Cha Y; Bae JM; Kim HP; Lyu J; Han H; Kim H; Jang H; Bang D; Huh I; Park T; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
    Cancer; 2017 Sep; 123(18):3513-3523. PubMed ID: 28513830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation analysis between abundance of K-ras mutation in plasma free DNA and its correlation with clinical outcome and prognosis in patients with metastatic colorectal cancer].
    Bai YQ; Liu XJ; Wang Y; Ge FJ; Zhao CH; Fu YL; Lin L; Xu JM
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):666-71. PubMed ID: 24332053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of DCC and Ki-ras gene alterations in colorectal carcinoma tissue as prognostic markers for liver metastatic recurrence.
    Kato M; Ito Y; Kobayashi S; Isono K
    Cancer; 1996 Apr; 77(8 Suppl):1729-35. PubMed ID: 8608570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases.
    Baldus SE; Schaefer KL; Engers R; Hartleb D; Stoecklein NH; Gabbert HE
    Clin Cancer Res; 2010 Feb; 16(3):790-9. PubMed ID: 20103678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The frequencies and clinical implications of mutations in 33 kinase-related genes in locally advanced rectal cancer: a pilot study.
    Abdul-Jalil KI; Sheehan KM; Toomey S; Schmid J; Prehn J; O'Grady A; Cummins R; O'Neill B; McNamara DA; Deasy J; Breathnach O; Grogan L; Rogers A; Doherty G; Winter D; Ryan J; El-Masry S; Gibbons D; Sheahan K; Gillen P; Kay EW; Hennessy BT
    Ann Surg Oncol; 2014 Aug; 21(8):2642-9. PubMed ID: 24700299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the metastasis suppressor gene KiSS1 is associated with lymph node metastasis and poor prognosis in human colorectal cancer.
    Okugawa Y; Inoue Y; Tanaka K; Toiyama Y; Shimura T; Okigami M; Kawamoto A; Hiro J; Saigusa S; Mohri Y; Uchida K; Kusunoki M
    Oncol Rep; 2013 Sep; 30(3):1449-54. PubMed ID: 23784200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancers.
    Fang WL; Huang KH; Lan YT; Lin CH; Chang SC; Chen MH; Chao Y; Lin WC; Lo SS; Li AF; Wu CW; Chiou SH; Shyr YM
    Oncotarget; 2016 Feb; 7(5):6201-20. PubMed ID: 26701847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive Spatiotemporal Stability of Somatic Mutations in Metastasized Microsatellite-stable Colorectal Cancer.
    Jesinghaus M; Wolf T; Pfarr N; Muckenhuber A; Ahadova A; Warth A; Goeppert B; Sers C; Kloor M; Endris V; Stenzinger A; Weichert W
    Am J Surg Pathol; 2015 Aug; 39(8):1140-7. PubMed ID: 25786087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paired Primary and Metastatic Tumor Analysis of Somatic Mutations in Synchronous and Metachronous Colorectal Cancer.
    Kim KP; Kim JE; Hong YS; Ahn SM; Chun SM; Hong SM; Jang SJ; Yu CS; Kim JC; Kim TW
    Cancer Res Treat; 2017 Jan; 49(1):161-167. PubMed ID: 27384156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAF.
    Hechtman JF; Zehir A; Yaeger R; Wang L; Middha S; Zheng T; Hyman DM; Solit D; Arcila ME; Borsu L; Shia J; Vakiani E; Saltz L; Ladanyi M
    Mol Cancer Res; 2016 Mar; 14(3):296-301. PubMed ID: 26660078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3K pathway mutations are associated with longer time to local progression after radioembolization of colorectal liver metastases.
    Ziv E; Bergen M; Yarmohammadi H; Boas FE; Petre EN; Sofocleous CT; Yaeger R; Solit DB; Solomon SB; Erinjeri JP
    Oncotarget; 2017 Apr; 8(14):23529-23538. PubMed ID: 28206962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Mutation Profiling of Colorectal Cancer Patients With Lung or Liver Metastasis by Targeted Next-Generation Sequencing.
    Hu CT; Wang JL; Hou T; Yan ZW; Zu LD; Fu GH; Shen WW
    Technol Cancer Res Treat; 2023; 22():15330338231185285. PubMed ID: 37394872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene heterogeneity in metastasis of colorectal cancer to the lung.
    Hou J; Zhang Y; Zhu Z
    Semin Cell Dev Biol; 2017 Apr; 64():58-64. PubMed ID: 27590223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analysis of Somatic Mutations in Colorectal Cancer With Peritoneal Metastasis.
    Lee JH; Ahn BK; Baik SS; Lee KH
    In Vivo; 2019; 33(2):447-452. PubMed ID: 30804124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer.
    Mathot L; Kundu S; Ljungström V; Svedlund J; Moens L; Adlerteg T; Falk-Sörqvist E; Rendo V; Bellomo C; Mayrhofer M; Cortina C; Sundström M; Micke P; Botling J; Isaksson A; Moustakas A; Batlle E; Birgisson H; Glimelius B; Nilsson M; Sjöblom T
    Cancer Res; 2017 Apr; 77(7):1730-1740. PubMed ID: 28108514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASO Author Reflections: Can We Predict an Unsalvageable Recurrence Following Colorectal Liver Metastasectomy?
    Okuno M; Conrad C
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):549-550. PubMed ID: 30565037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.